University, Subject, Country, Region, World

Harvard University Scientist Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences Rankings 2023

AD Scientific Index analyzes academic studies from 1 countries, 1 universities/institutions, and 33 scientists by using H index, i10 index and citation count criteria to present results to be used for the evaluation of productivity and efficiency by individuals and institutions. In addition to the ranking by "total H-index", you can also see the ranking and analysis by "last 6 years H-index", "total i10 index", "last 6 years i10 index", "total citations", and “last 6 years citations”. Please see the methodology for "Limitations and Possible Reasons for Not Including a Scientist in this List". Click for individual or institutional registration.

AD Scientific Index - World Scientist Rankings - 2023 H INDEX i10 INDEX CITATION
University / Institution Country Region World Name Country University / Institution Subject Total Last 6 year Last 6 year/total Total Last 6 year Last 6 year/total Total Last 6 year Last 6 year/total
75 694 742 1558
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

pharmacoepidemiology | side effects | drug policy | academic detailing | prescription drugs |

144 72 0.500 524 315 0.601 115743 27939 0.241
411 6006 6543 12819
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Pharmaceutical policy | health systems research | quality improvement |

85 48 0.565 264 189 0.716 28079 9895 0.352
450 7026 7659 15079
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

disease surveillance | infectious disease outbreaks | scan statistics | pharmacoepidemiology | vaccine safety |

81 44 0.543 194 140 0.722 29372 9039 0.308
731 15010 16593 34810
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

medicinal chemistry |

63 25 0.397 203 52 0.256 13400 2115 0.158
995 24446 27295 60375
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

medicinal chemistry | antitumor and antiviral agents |

52 10 0.192 200 12 0.060 9537 635 0.067
998 24506 27363 60543
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

causal inference | hierarchical modeling | pharmacoepidemiology |

52 47 0.904 116 106 0.914 9275 7070 0.762
1212 32039 35987 83186
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Pharmacoepidemiology | Privacy-protecting methods | Distributed data networks | Real-world evidence |

46 34 0.739 112 104 0.929 6970 4443 0.637
1231 32953 37013 85833
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Pharmacoepidemiology | real-world evidence | medical product safety and effectiveness |

45 36 0.800 158 135 0.854 8692 5724 0.659
1397 38644 43534 103907
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

pharmacology | burn injury | opiates |

42 14 0.333 105 28 0.267 5522 1018 0.184
1472 42033 47380 114730
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Computational systems biology | real time | hybrid and probabilistic systems. |

40 13 0.325 92 19 0.207 5686 977 0.172

The most comprehensive analysis and comparisons about your institution

1519 43764 49350 120212
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Pharmacoepidemiology |

39 36 0.923 93 86 0.925 6060 5365 0.885
2439 80600 91176 249736
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Cardiovascular pharmacotherapy | pharmacology and pharmacoepidemiology |

27 27 1.000 46 45 0.978 2572 2435 0.947
2630 88137 99709 277377
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Pharmacoepidemiology | Health Law | Immune Thrombocytopenia |

25 22 0.880 53 44 0.830 3052 2115 0.693
2642 88706 100357 279435
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Pharmacoepidemiology | outcomes research | pharmacogenomics | pharmacogenetics |

25 13 0.520 32 18 0.563 2704 591 0.219
2905 98982 111970 318182
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Medicinal Chemistry | Molecular Imaging | Drug Discovery and Evaluation |

23 9 0.391 30 9 0.300 2461 865 0.351
3122 107103 121115 349618
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

pharmacoepidemiology | methods |

22 18 0.818 27 25 0.926 1651 1323 0.801
3272 112011 126638 367342
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Pharmacogenomics and Placebo Response |

21 17 0.810 29 25 0.862 1894 1040 0.549
3542 122375 138337 410507
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Computational Medicine | Pharmacometrics | Process Engineering | Numerical Techniques | Machine Learning |

20 17 0.850 24 19 0.792 1016 559 0.550
3736 127987 144599 428854
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Respiratory Disease | Pulmonary Hypertension | Pulmonary Fibrosis | BMP/TGFβ | GPCR |

19 18 0.947 21 20 0.952 1354 1174 0.867
3766 128957 145689 433584
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Nanopharmaceuticals | bone tissue engineering | Targeted drug delivery | Nonviral gene delivery systems |

19 19 1.000 20 20 1.000 1207 1121 0.929
3775 129389 146172 435913
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Computational Biology |

19 18 0.947 19 19 1.000 1134 1043 0.920
3918 133967 151249 451365
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

pharmacoepidemiology | health services research |

18 17 0.944 30 28 0.933 1618 1178 0.728
4008 137140 154825 464910
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Infectious Diseases | Antimicrobial Chemotherapy | Pharmacy |

18 15 0.833 21 18 0.857 1120 644 0.575
4017 137533 155270 466961
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Pharmacoepidemiology | Clinical epidemiology | registry studies |

18 16 0.889 24 23 0.958 1067 874 0.819
4304 148574 167635 513106
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Pharmaceutical Medicine | Public Health |

16 11 0.688 18 12 0.667 13036 5858 0.449
4786 163348 184003 564927
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Medicinal Chemistry | Drug Delivery | Pharmacology | Biomedical Engineering | Biophysics |

15 14 0.933 16 14 0.875 1175 1041 0.886
5606 189586 213137 666520
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Pharmaceuticals | Medicinal Chemistry |

13 8 0.615 14 8 0.571 754 202 0.268
5697 194601 218774 694417
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Angiogenesis | Pharmacology | Cancer | Ocular Disease | High-throughput Screening |

13 9 0.692 13 8 0.615 417 163 0.391
5995 203712 228820 723983
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Health economics | pharmacoepidemiology | outcomes research |

12 10 0.833 15 11 0.733 592 456 0.770
6351 216091 242501 772769
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

pharmacoepidemiology | causal inference | infectious disease |

11 11 1.000 12 11 0.917 560 474 0.846
6993 241627 270573 877410
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Medicinal Chemistry |

9 7 0.778 9 7 0.778 486 166 0.342
7113 249081 278759 919780
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Pharmacovigilance | Harm Reduction | Cryptomarkets | Behavioral Economics | Drug Policy |

8 8 1.000 6 6 1.000 917 728 0.794
7124 249451 279168 920642
United States Harvard University Harvard University Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences

Pharmacy | Critical Care | Transitions of Care |

8 8 1.000 8 8 1.000 832 446 0.536